Join to View Full Profile
333 Cedar StNew Haven, CT 06510
Phone+1 203-785-2360
Fax+1 203-785-4116
Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Johns Hopkins UniversityResidency, Internal Medicine, 2009 - 2012
Topiwala National Medical CollegeClass of 2007
Certifications & Licensure
CT State Medical License 2015 - 2025
PA State Medical License 2010 - 2015
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck Start of enrollment: 2017 Mar 24
- Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer Start of enrollment: 2019 Aug 16
Roles: Principal Investigator
Publications & Presentations
PubMed
- Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck.Aarti Bhatia, Ranee Mehra, Jessica Bauman, Saad A Khan, Wei Wei
Head & Neck. 2025-04-01 - 11 citationsRandomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.Julie E Bauman, Nabil F Saba, Denise Roe, Jessica R Bauman, John Kaczmar
Journal of Clinical Oncology. 2023-08-01 - 3 citationsEvaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety...Annika Belzer, Jolanta Pach, Ryland D Mortlock, James Clune, Kelly Olino
JAAD International. 2023-06-01
Journal Articles
- Adjuvant Chemotherapy Is Associated with Improved Survival for Late‐Stage Salivary Squamous Cell CarcinomaHenry S Park, Shayan Cheraghlou, Benjamin L Judson, Aarti Bhatia, Saral Mehra, Amy Schettino, Wendell G Yarbrough, Michael D Otremba, The Laryngoscope
Press Mentions
Emerging Therapies Show Promise in Head and Neck CancerMay 4th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
